Search for: "Steven J. Willis" Results 21 - 40 of 85
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2018, 3:42 am by Brian Cordery
Brian Corderyby Steven Willis and Olivia Henry On 28 March 2018, the Court of Appeal overturned Henry Carr J’s finding that two Regeneron patents (EP (UK) 1 360 287 and EP (UK) 2 264 163) were insufficient. [read post]
9 May 2017, 12:59 pm
Steven Willis (Bristows) updates readers the Court of Appeal’s decision in the first of the three related technical trials to receive judgment from the Patents Court in 2015/16. [read post]
24 Apr 2017, 9:14 am
  With the AmeriKat busy at Fordham, she has depended on Steven Willis (Bristows) to update readers:  "The patent in suit concerned a polling system for use in a wireless communication network. [read post]
20 Apr 2017, 2:44 am by Brian Cordery
Brian Corderyby Steven Willis Given the furore surrounding Birss J’s decision on the non-technical issues in Unwired Planet v Huawei earlier this month, which included the first determination of FRAND terms by an English Court (reported on by my colleague Rachael here), it would have been easy to miss the first appellate Court judgment on the related technical issues which was handed down last week. [read post]
25 Jan 2017, 10:48 pm
  For those that were busy braving the dark London streets for last minute present buying instead, the ever succinct Steven Willis (Bristows) reports on the evening's festivities: "Andrew recapped that in 2016, there were 18 Patents Court judgments on issues of validity and/or infringement. [read post]
16 Jan 2017, 6:45 am by Brian Cordery
Brian CorderyBristowsby Steven Willis In a judgment handed down at the end of last week, Arnold J has indicated his intention to make a reference to the CJEU concerning the interpretation of Article 3(d) of the SPC Regulation i.e. the requirement for the marketing authorisation (“MA”) on which an SPC application is based to be the first MA placing the product (active ingredient or combination of active ingredients) on the market as a medicinal product. [read post]
22 Dec 2016, 9:10 am by Brian Cordery
Brian CorderyBristowsby Steven Willis Yesterday, the Patents Court handed down yet another decision in the Sisyphean pregablin litigation, this time refusing Sandoz’ application to vary the Order for Injunction which resulted from Arnold J’s October 2015 decision (“Sandoz I”) to injunct Sandoz following its launch of a full label pregabalin product (“Pregabalin Sandoz”). [read post]
16 Dec 2016, 4:44 am
.* AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringementIn a guest post, Kat friend Steven Willis recaps 3 keynote experts’ latest revisits to Warner-Lambert’s patent issues, which covers the plausibility/insufficiency aspects of the Court of Appeal judgment, the amendment and related abuse of process issues and the thorny area of the construction and infringement of Swiss type claims. [read post]
7 Dec 2016, 11:58 pm
  Steven Willis (Bristows) reports:  "Since that first rapid response seminar, Arnold J has issued a further judgment concerning Warner-Lambert’s right to amend the Patent after the trial and whether that amounted to an abuse of process (Generics (UK) t/a Mylan v Warner-Lambert [2015] EWHC 3370 (Pat)). [read post]
16 Nov 2016, 3:44 am
 Struck by this (and because her eyes glazed over that part of the decision), she asked Steven Willis (Bristows) to educate her and our readers about this aspect of the case. [read post]
9 Nov 2016, 4:53 am by Brian Cordery
Brian CorderyBristowsby Steven Willis Yesterday, the Court of Appeal handed down its decision in Idenix v Gilead [2016] EWCA Civ 1089, a dispute involving SOVALDI® (sofosbuvir), which is sold by Gilead as a treatment for chronic hepatitis C infection in adults. [read post]
13 Oct 2016, 6:50 am by Brian Cordery
Brian CorderyBristowsby Brian Cordery, Rachel Mumby and Steven Willis Media attention at the English High Court today may have been focussed on the Article 50 challenge but for many patent lawyers operating in the life sciences sector, of equal or greater importance was the handing down of the long-awaited judgment in the Lyrica appeal. [read post]
2 Aug 2016, 8:45 am by azatty
Vakula as President-Elect, Jeffrey Willis as First Vice President, Steven A. [read post]
2 Jan 2015, 10:30 am by Paul Caron
Above the Law, Use Your Year-End Bonus Wisely to Catch a Tax Break Brief of Washington Legal Foundation and Steven J. [read post]